838
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Formulation and Clinical Efficacy of Myrrh Extract in Hard Gelatin Capsules

, , , , &
Pages 72-86 | Received 25 Oct 2012, Accepted 27 Nov 2012, Published online: 07 Jun 2013
 

Abstract

The development of myrrh extract from natural origin capable of eradication of schistosomal infections has gained the interest of many scientists. Recently; myrrh extract is considered as the drug of choice from natural origin used to treat Schistosomiasis. This work includes the preparation of myrrh extract by maceration and the formulation of these extracts in hard gelatin capsules as a pharmaceutical dosage form followed by clinical investigation of the effectiveness of these capsules. As a result, myrrh extract capsules with different doses showed a variable effectiveness against Schistosoma mansoni (S. mansoni) with different severity but n-hexane extract capsules showed better effectiveness in comparison to alcohol extract capsules. The percent cure increased by increasing the treatment time. In additions the number of positive cases decreased by increasing the treatment time. On the contrary, increasing the severity of the infection from mild to heavy cases led to decrease the cure percent and increased the number of the positive cases. There was a significant reduction of infection intensity in cases which were incompletely cured. It could be concluded from these results that hard gelatin capsules of myrrh extract are highly effective as a pharmaceutical dosage form against Schistosomiasis.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.